BR9805993B1 - composição farmacêutica de aerossol. - Google Patents

composição farmacêutica de aerossol.

Info

Publication number
BR9805993B1
BR9805993B1 BRPI9805993-9A BR9805993A BR9805993B1 BR 9805993 B1 BR9805993 B1 BR 9805993B1 BR 9805993 A BR9805993 A BR 9805993A BR 9805993 B1 BR9805993 B1 BR 9805993B1
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
aerosol pharmaceutical
aerosol
composition
pharmaceutical
Prior art date
Application number
BRPI9805993-9A
Other languages
English (en)
Portuguese (pt)
Other versions
BR9805993A (pt
Inventor
David Lewis
David Ganderton
Brian Meakin
Paolo Ventura
Gaetano Brambilla
Raffaella Garzia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9805993(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of BR9805993A publication Critical patent/BR9805993A/pt
Publication of BR9805993B1 publication Critical patent/BR9805993B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI9805993-9A 1997-06-13 1998-06-10 composição farmacêutica de aerossol. BR9805993B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions
PCT/EP1998/003533 WO1998056349A1 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition

Publications (2)

Publication Number Publication Date
BR9805993A BR9805993A (pt) 1999-08-31
BR9805993B1 true BR9805993B1 (pt) 2009-05-05

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9805993-9A BR9805993B1 (pt) 1997-06-13 1998-06-10 composição farmacêutica de aerossol.

Country Status (44)

Country Link
EP (2) EP0920302B2 (enExample)
JP (1) JP4380802B2 (enExample)
KR (1) KR100546239B1 (enExample)
CN (1) CN1138532C (enExample)
AR (1) AR012977A1 (enExample)
AT (1) ATE222751T1 (enExample)
AU (1) AU729966B2 (enExample)
BG (1) BG63906B1 (enExample)
BR (1) BR9805993B1 (enExample)
CA (1) CA2263445C (enExample)
CO (1) CO4940408A1 (enExample)
CZ (1) CZ295521B6 (enExample)
DE (1) DE69807420T3 (enExample)
DK (1) DK0920302T4 (enExample)
DZ (1) DZ2516A1 (enExample)
EA (1) EA001259B1 (enExample)
EE (1) EE03664B1 (enExample)
ES (1) ES2182351T5 (enExample)
GB (1) GB2326334A (enExample)
GE (1) GEP20012462B (enExample)
HR (1) HRP980317B1 (enExample)
HU (1) HU228487B1 (enExample)
ID (1) ID21491A (enExample)
IL (1) IL128484A (enExample)
IN (1) IN189317B (enExample)
IS (1) IS2435B (enExample)
IT (1) IT1293803B1 (enExample)
MA (1) MA26507A1 (enExample)
ME (2) MEP44008A (enExample)
MY (1) MY119074A (enExample)
NO (1) NO327775B1 (enExample)
NZ (1) NZ334149A (enExample)
PL (1) PL193721B1 (enExample)
PT (1) PT920302E (enExample)
RS (1) RS51274B (enExample)
SA (1) SA98190821B1 (enExample)
SI (1) SI0920302T2 (enExample)
SK (1) SK284430B8 (enExample)
TN (1) TNSN98087A1 (enExample)
TR (1) TR199900288T1 (enExample)
TW (1) TW555570B (enExample)
UA (1) UA70289C2 (enExample)
WO (1) WO1998056349A1 (enExample)
ZA (1) ZA985136B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
FR2798290B1 (fr) 1999-09-11 2003-09-12 Glaxo Group Ltd Formulation pharmaceutique de propionate de fluticasone
JP2003514841A (ja) * 1999-11-23 2003-04-22 グラクソ グループ リミテッド サルメテロールの医薬製剤
WO2001047493A1 (en) * 1999-12-24 2001-07-05 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
AU5070100A (en) 2000-05-22 2001-12-03 Chiesi Farma Spa Stable pharmaceutical solution formulations for pressurised metered dose inhalers
WO2002072067A2 (en) * 2001-03-12 2002-09-19 Glaxo Group Limited Pharmaceutical aerosol formulation
EP1273292B1 (en) 2001-07-02 2004-05-26 CHIESI FARMACEUTICI S.p.A. Optimised formulation of tobramycin for aerosolization
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
SI3494995T1 (sl) 2002-03-01 2020-08-31 Chiesi Farmaceutici S.P.A. Superfina formulacija formoterola
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
DE60216242T2 (de) * 2002-06-06 2007-05-24 Chiesi Farmaceutici S.P.A. Lösung von Wirkstoffen in HFA-Treibgasen mittels Emulsionen
WO2004071488A1 (en) * 2003-02-04 2004-08-26 Chrysalis Technologies Incorporated Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
EA009087B1 (ru) 2003-03-20 2007-10-26 Бёрингер Ингельхайм Фармасьютиклз, Инк. Состав для ингалятора, выдающего мерную дозу препарата, с использованием гидрофторалканов в качестве пропеллентов
EP1915985A1 (en) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
SE0303179D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
PL1809243T5 (pl) 2004-07-02 2022-12-27 Boehringer Ingelheim International Gmbh Preparaty aerozolowe w postaci zawiesin z tg 227 ea jako propelent aerozolowy
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) * 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
BRPI0819259A2 (pt) * 2007-11-07 2019-10-01 Astrazeneca Ab formulações de pó seco compreendendo derivados do ácido ascórbico.
RU2561833C2 (ru) * 2010-09-06 2015-09-10 Кьези Фармасьютичи С.П.А. Дозирующий ингалятор и способ его применения
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
EP2819669B1 (de) 2012-02-28 2021-04-21 Boehringer Ingelheim International GmbH Neue treibgashaltige tiotropium-formulierung
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
US20170189329A1 (en) 2014-07-29 2017-07-06 3M Innovative Properties Company Method of preparing a pharmaceutical composition
EP3436115B1 (en) 2016-03-31 2021-07-28 Chiesi Farmaceutici S.p.A. Aerosol inhalation device
JP6781832B2 (ja) * 2016-09-19 2020-11-04 メキシケム フロー エセ・ア・デ・セ・ヴェ 医薬組成物
WO2025039045A1 (en) * 2023-08-23 2025-02-27 Inhaler Supplies Pty Ltd Inhalable formulation for volatile actives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2038696T3 (es) † 1986-03-10 1996-07-16 Burghart Kurt Procedimiento para producir un preparado farmaceutico.
US4863720A (en) † 1986-03-10 1989-09-05 Walter Burghart Pharmaceutical preparation and methods for its production
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
JP2769925B2 (ja) † 1990-10-18 1998-06-25 ミネソタ マイニング アンド マニュファクチャリング カンパニー ベクロメタゾン１７，２１ジプロピオネートを含んで成るエアロゾル製剤
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ES2180592T3 (es) † 1991-06-10 2003-02-16 Schering Corp Formulaciones en aerosol libres de clorofluorocarbonos.
US5474759A (en) * 1991-06-10 1995-12-12 Schering Corporation Non-chlorofluorocarbon aerosol formulations
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DE69205177T2 (de) * 1991-12-12 1996-03-21 Glaxo Group Ltd., Greenford, Middlesex Pharmazeutische Aerosolformulierung.
AU675633B2 (en) * 1991-12-18 1997-02-13 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
WO1994013262A1 (en) * 1992-12-09 1994-06-23 Boehringer Ingelheim Pharmaceuticals, Inc. Stabilized medicinal aerosol solution formulations
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
WO1995031182A1 (en) † 1994-05-13 1995-11-23 Aradigm Corporation Narcotic containing aerosol formulation
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
ES2244008T3 (es) † 1996-12-04 2005-12-01 Link Products Limited Composiciones farmaceuticas y dispositivos para su administracion.
JP2001511160A (ja) † 1997-02-05 2001-08-07 ヤゴ リサーチ アクチェンゲゼルシャフト 医学用エアゾール配合物

Also Published As

Publication number Publication date
IS4974A (is) 1999-02-11
IL128484A0 (en) 2000-01-31
SK284430B6 (sk) 2005-04-01
PT920302E (pt) 2002-11-29
JP2000516965A (ja) 2000-12-19
EE03664B1 (et) 2002-04-15
AR012977A1 (es) 2000-11-22
BG63906B1 (bg) 2003-06-30
TR199900288T1 (xx) 1999-09-21
HRP980317B1 (en) 2002-06-30
SK284430B8 (sk) 2005-05-05
EP0920302B2 (en) 2006-06-21
SK17699A3 (en) 1999-07-12
RS51274B (sr) 2010-12-31
MEP44008A (hr) 2011-02-10
DK0920302T4 (da) 2006-10-09
EP0920302B1 (en) 2002-08-28
ID21491A (id) 1999-06-17
ATE222751T1 (de) 2002-09-15
ZA985136B (en) 1999-01-07
BR9805993A (pt) 1999-08-31
SI0920302T2 (sl) 2006-10-31
DZ2516A1 (fr) 2004-11-08
EP1219293A3 (en) 2003-05-28
IL128484A (en) 2004-09-27
CZ295521B6 (cs) 2005-08-17
EP1219293A2 (en) 2002-07-03
WO1998056349A1 (en) 1998-12-17
NO990594D0 (no) 1999-02-09
CA2263445A1 (en) 1998-12-17
BG103221A (bg) 1999-09-30
CZ46299A3 (cs) 1999-07-14
IN189317B (enExample) 2003-02-08
DE69807420D1 (de) 2002-10-02
CO4940408A1 (es) 2000-07-24
MA26507A1 (fr) 2004-12-20
DE69807420T3 (de) 2006-11-16
HUP0001339A3 (en) 2000-10-30
EE9900055A (et) 1999-08-16
TNSN98087A1 (fr) 2005-03-15
NZ334149A (en) 2000-07-28
EA199900201A1 (ru) 1999-06-24
KR20000068171A (ko) 2000-11-25
CN1138532C (zh) 2004-02-18
CN1229355A (zh) 1999-09-22
YU6999A (sh) 2000-03-21
PL331531A1 (en) 1999-07-19
AU729966B2 (en) 2001-02-15
HRP980317A2 (en) 1999-04-30
JP4380802B2 (ja) 2009-12-09
AU8626298A (en) 1998-12-30
SA98190821B1 (ar) 2006-11-19
GEP20012462B (en) 2001-06-25
KR100546239B1 (ko) 2006-01-26
EA001259B1 (ru) 2000-12-25
DK0920302T3 (da) 2002-12-23
IT1293803B1 (it) 1999-03-10
SI0920302T1 (sl) 2002-12-31
ME00333B (me) 2011-02-10
ITMI971798A1 (it) 1999-01-28
DE69807420T2 (de) 2003-05-08
HK1022271A1 (en) 2000-08-04
CA2263445C (en) 2008-09-09
ES2182351T5 (es) 2007-03-16
NO990594L (no) 1999-04-13
TW555570B (en) 2003-10-01
EP0920302A1 (en) 1999-06-09
MY119074A (en) 2005-03-31
NO327775B1 (no) 2009-09-21
GB9712434D0 (en) 1997-08-13
HUP0001339A2 (hu) 2000-09-28
UA70289C2 (uk) 2004-10-15
ES2182351T3 (es) 2003-03-01
PL193721B1 (pl) 2007-03-30
GB2326334A (en) 1998-12-23
HU228487B1 (en) 2013-03-28
IS2435B (is) 2008-10-15

Similar Documents

Publication Publication Date Title
BR9805993B1 (pt) composição farmacêutica de aerossol.
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
NO20005218D0 (no) Farmasøytisk aerosolpreparat
TR199901077A3 (tr) Ispençiyari formülasyonlar.
ID27415A (id) Komposisi farmaseutik
ID29262A (id) Komposisi farmasi
ID27201A (id) Komposisi farmasi
ZA989680B (en) Pharmaceutical composition.
ID29294A (id) Komposisi farmasi
ZA987392B (en) Pharmaceutical composition.
ID25857A (id) Komposisi farmasi
ID18698A (id) Komposisi farmasi
ID26215A (id) Komposisi farmasi
ITMI962628A0 (it) Composizione farmaceutica
ID23531A (id) Komposisi farmasi
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
PT1041984E (pt) Composicao farmaceutica bebivel
BR1100755A (pt) composição farmacêutica
ZA982367B (en) Pharmaceutical compositions.
TR199500776A2 (tr) Farmasötik bilesimler.
ES1038714Y (es) Dispensador de palillos de dientes.
SE9604299D0 (sv) Pharmaceutical composition
SE9601854D0 (sv) Farmaceutisk komposition
ID17133A (id) Komposisi farmasi
FI3163U1 (fi) Lääkesäiliö

Legal Events

Date Code Title Description
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 28/07/2009, OBSERVADAS AS CONDICOES LEGAIS.

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent
B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI NO 52400.115898/2018-48 ORIGEM: 25A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO: 5002419-06.2018.4.02.5101/RJ AUTOR: GLENMARK FARMACEUTICA LTDA REU: INPI-INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL REU: CHIESI FARMACEUTICI S.P.A. DECISAO: ANTE O EXPOSTO, JULGO PROCEDENTE EM PARTE O PEDIDO DA PARTE AUTORA, NOS TERMOS DO ARTIGO 487, INCISO I, DO CPC, PARA DETERMINAR O APOSTILAMENTO DA PI9805993-9, COM A INCORPORACAO DA REINVINDICACAO 7 DE SOLUCAO A REIVINDICACAO 1, E PARA DECLARAR A NULIDADE DA PI0107730-9, POR INEXISTIR ATIVIDADE INVENTIVA.